Literature DB >> 26422415

Racial differences in adherence and response to combined treatment for full and subthreshold post-traumatic stress disorder and alcohol use disorders: A secondary analysis.

Lesia M Ruglass1, Annelisa Pedersen1, Soumia Cheref2, Mei-Chen Hu3, Denise A Hien4.   

Abstract

We conducted a secondary data analysis to examine whether there were racial differences in adherence and treatment outcomes for participants with co-occurring full and subthreshold post-traumatic stress disorder (PTSD) and alcohol/substance use disorders (A/SUD) who were treated with Seeking Safety (a cognitive-behavioral therapy) and sertraline or Seeking Safety and placebo as part of a clinical trial. Bivarate analyses examined the association between race and adherence, and generalized estimating equations assessed whether race moderated the effect of combination treatment on PTSD and alcohol use outcomes. Except for education, there were no statistically significant racial differences in baseline demographic and psychiatric characteristics. African Americans and Caucasians were equally adherent in number of psychotherapy and medication sessions attended and medication compliance. After controlling for baseline demographics and psychiatric symptoms, however, a race by treatment condition interaction emerged suggesting that African Americans who received the Seeking Safety and sertraline treatment had significantly lower PTSD symptom severity posttreatment and at six months follow-up compared to their counterparts who received Seeking Safety and placebo. No differential effect of treatment condition was found for Caucasians. Moreover, results indicated that a diagnosis of major depressive disorder negatively impacted PTSD symptom recovery for African American participants but not for Caucasians. In conclusion, no differences emerged between African Americans and Caucasians in adherence to combination treatments for PTSD and A/SUD. Findings also suggest assessment and treatment of MDD among African Americans may improve treatment outcomes. More research is needed to determine whether the differential response to Seeking Safety and sertraline among African Americans compared to Caucasians can be replicated.

Entities:  

Keywords:  Alcohol use disorders; PTSD; racial differences; seeking safety; sertraline; substance use disorders

Mesh:

Substances:

Year:  2015        PMID: 26422415      PMCID: PMC5581661          DOI: 10.1080/15332640.2015.1056927

Source DB:  PubMed          Journal:  J Ethn Subst Abuse        ISSN: 1533-2640            Impact factor:   1.507


  45 in total

Review 1.  Pharmacogenetics of antidepressants, mood stabilizers, and antipsychotics in diverse human populations.

Authors:  Eleanor Murphy; Francis J McMahon
Journal:  Discov Med       Date:  2013-09       Impact factor: 2.970

2.  Subthreshold PTSD in primary care: prevalence, psychiatric disorders, healthcare use, and functional status.

Authors:  Anouk L Grubaugh; Kathryn M Magruder; Angela E Waldrop; Jon D Elhai; Rebecca G Knapp; B Christopher Frueh
Journal:  J Nerv Ment Dis       Date:  2005-10       Impact factor: 2.254

Review 3.  Helping vulnerable populations: a comprehensive review of the treatment outcome literature on substance use disorder and PTSD.

Authors:  Lisa M Najavits; Denise Hien
Journal:  J Clin Psychol       Date:  2013-05

Review 4.  At the crossroads: the intersection of substance use disorders, anxiety disorders, and posttraumatic stress disorder.

Authors:  Lesia M Ruglass; Teresa Lopez-Castro; Soumia Cheref; Santiago Papini; Denise A Hien
Journal:  Curr Psychiatry Rep       Date:  2014-11       Impact factor: 5.285

5.  Longitudinal data analysis for discrete and continuous outcomes.

Authors:  S L Zeger; K Y Liang
Journal:  Biometrics       Date:  1986-03       Impact factor: 2.571

6.  Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Kathleen R Merikangas; Ellen E Walters
Journal:  Arch Gen Psychiatry       Date:  2005-06

7.  Effects of race and ethnicity on depression treatment outcomes: the CO-MED trial.

Authors:  Ira M Lesser; Sidney Zisook; Bradley N Gaynes; Stephen R Wisniewski; James F Luther; Maurizio Fava; Ahsan Khan; Patrick McGrath; Diane Warden; A John Rush; Madhukar Trivedi
Journal:  Psychiatr Serv       Date:  2011-10       Impact factor: 3.084

8.  The epidemiology of major depressive disorder: results from the National Comorbidity Survey Replication (NCS-R).

Authors:  Ronald C Kessler; Patricia Berglund; Olga Demler; Robert Jin; Doreen Koretz; Kathleen R Merikangas; A John Rush; Ellen E Walters; Philip S Wang
Journal:  JAMA       Date:  2003-06-18       Impact factor: 56.272

9.  Racial/ethnic disparities in alcohol-related problems: differences by gender and level of heavy drinking.

Authors:  Jane Witbrodt; Nina Mulia; Sarah E Zemore; William C Kerr
Journal:  Alcohol Clin Exp Res       Date:  2014-04-14       Impact factor: 3.455

Review 10.  Disparities in Latino substance use, service use, and treatment: implications for culturally and evidence-based interventions under health care reform.

Authors:  Erick G Guerrero; Jeanne C Marsh; Tenie Khachikian; Hortensia Amaro; William A Vega
Journal:  Drug Alcohol Depend       Date:  2013-08-02       Impact factor: 4.492

View more
  2 in total

1.  Do race/ethnicity and religious affiliation moderate treatment outcomes among individuals with co-occurring PTSD and substance use disorders?

Authors:  Lesia M Ruglass; Ann M Yali
Journal:  J Prev Interv Community       Date:  2019-05-11

2.  Ethnoracial differences in treatment-seeking veterans with substance use disorders and co-occurring PTSD: Presenting characteristics and response to integrated exposure-based treatment.

Authors:  Delisa G Brown; Julianne C Flanagan; Amber Jarnecke; Therese K Killeen; Sudie E Back
Journal:  J Ethn Subst Abuse       Date:  2020-10-28       Impact factor: 1.331

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.